DK350876A - Ekstrakter af det hemopoietiske system - Google Patents

Ekstrakter af det hemopoietiske system

Info

Publication number
DK350876A
DK350876A DK350876A DK350876A DK350876A DK 350876 A DK350876 A DK 350876A DK 350876 A DK350876 A DK 350876A DK 350876 A DK350876 A DK 350876A DK 350876 A DK350876 A DK 350876A
Authority
DK
Denmark
Prior art keywords
extracts
hemopoietic system
hemopoietic
Prior art date
Application number
DK350876A
Other languages
Danish (da)
English (en)
Inventor
W A Jones
T L S T H Yuen
T Rytomaa
N J Harper
H F Frost
Original Assignee
Union International Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union International Co Ltd filed Critical Union International Co Ltd
Publication of DK350876A publication Critical patent/DK350876A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/18Erythrocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK350876A 1975-08-05 1976-08-04 Ekstrakter af det hemopoietiske system DK350876A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32659/75A GB1579120A (en) 1975-08-05 1975-08-05 Extracts of the haemopoietic system

Publications (1)

Publication Number Publication Date
DK350876A true DK350876A (da) 1977-02-06

Family

ID=10342062

Family Applications (1)

Application Number Title Priority Date Filing Date
DK350876A DK350876A (da) 1975-08-05 1976-08-04 Ekstrakter af det hemopoietiske system

Country Status (19)

Country Link
US (1) US4294824A (fr)
JP (1) JPS5218807A (fr)
AR (1) AR211931A1 (fr)
AU (1) AU515950B2 (fr)
BE (1) BE844875A (fr)
CA (1) CA1063019A (fr)
DE (1) DE2635065C2 (fr)
DK (1) DK350876A (fr)
FI (1) FI762178A (fr)
FR (1) FR2320106A1 (fr)
GB (1) GB1579120A (fr)
IE (1) IE44378B1 (fr)
IN (1) IN144537B (fr)
IT (1) IT1062655B (fr)
LU (1) LU75535A1 (fr)
NL (1) NL7608651A (fr)
NZ (1) NZ181653A (fr)
SE (1) SE7608771L (fr)
ZA (1) ZA764643B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU182087B (en) * 1980-01-15 1983-12-28 Mta Kiserleti Orvostudomanyi K Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia
JPS6339609Y2 (fr) * 1980-11-21 1988-10-18
JPS59141520A (ja) * 1983-02-02 1984-08-14 Kyowa Hakko Kogyo Co Ltd Dna合成抑制物質
US5711881A (en) * 1992-04-12 1998-01-27 Toray Industries, Inc. Hematopoietic inhibiting factor containing compositions
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
ATE268810T1 (de) * 1995-12-21 2004-06-15 Genzyme Corp Methode zur zellyse
FR2773818B1 (fr) * 1998-01-21 2000-02-18 Pasteur Merieux Serums Vacc Procede et dispositif de lyse de bacteries
ATE276356T1 (de) 1998-03-26 2004-10-15 Viranative Ab Verfahren zur kontinuierlichenaufreinigung und konzentrierung von leukozyten aus blut
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6664049B1 (en) * 1999-01-20 2003-12-16 Aventis Pasteur S.A. Method and device for cell lysis
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
EP1640012A1 (fr) * 2004-09-24 2006-03-29 Salama, Zoser B. nat.rer.Dr. Agents pharmaceutiques comprenant des constituants du sang 10 kDa et l'utilisation dans la prophylaxe et dans le traitement des troubles du système immunitaire
DE102004047262A1 (de) * 2004-09-24 2006-04-06 Ipss International Pharmaceutical Strategies & Solutions Pharmazeutisches Mittel umfassend Blutprodukte und deren Verwendung als Injektions- oder Infusionsmittel zur Prophylaxe und Behandlung von Defekten des Immunsystems beim Menschen
US20060067942A1 (en) * 2004-09-24 2006-03-30 Salama Zoser B Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals

Also Published As

Publication number Publication date
JPS5218807A (en) 1977-02-12
DE2635065C2 (de) 1983-10-27
IE44378B1 (en) 1981-11-04
LU75535A1 (fr) 1978-02-13
IN144537B (fr) 1978-05-13
NZ181653A (en) 1979-01-11
CA1063019A (fr) 1979-09-25
DE2635065A1 (de) 1977-02-17
AU515950B2 (en) 1981-05-14
FR2320106B1 (fr) 1980-11-07
AR211931A1 (es) 1978-04-14
IT1062655B (it) 1984-10-20
GB1579120A (en) 1980-11-12
US4294824A (en) 1981-10-13
IE44378L (en) 1977-02-05
SE7608771L (sv) 1977-02-06
NL7608651A (nl) 1977-02-08
ZA764643B (en) 1978-03-29
FR2320106A1 (fr) 1977-03-04
BE844875A (fr) 1977-02-04
AU1661476A (en) 1978-02-09
FI762178A (fr) 1977-02-06

Similar Documents

Publication Publication Date Title
SE415436B (sv) Televisionssystem
SE7611217L (sv) Telekonferenssystem
DK320977A (da) Fremgangsmade til fremstilling af bindemidler til elektrodyppelakering
LU88282I2 (fr) Anandron
BR7601529A (pt) Chuveiro aperfeicoado
SE7604607L (sv) Tradlindningsanslutning
RO73090A (fr) Embout
DK321177A (da) Fremgangsmade til fremstilling af bindemidler til elektrodyppelakering
FR2300037A1 (fr) System
DK550576A (da) Fremgangsmade til fremstilling af argininderivater
AT335804B (de) Fitting
DK350876A (da) Ekstrakter af det hemopoietiske system
FR2328154A1 (fr) Raccord de reduction
FR2300190A1 (fr) Element de parement
SE7611414L (sv) Prostaglandinderivat
DK385276A (da) Flangeforbindelse
FI772463A (fi) Anvaendning av det magnettekniska systemet
SE385533B (sv) Tvaapparatsystem
DK318876A (da) Fremgangsmade til fremstilling af prostaglandinanaloge
DK517176A (da) Fremstilling af ethylchlorthioformiat
DK435776A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK435876A (da) Fremgangsmade til fremstilling af phosphitchlorider
SE7607033L (sv) Duschkar
FR2338264A1 (fr) Hydantoines
DK66176A (da) Fremgangsmade til fremstilling af substituerede imidazoler

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment